Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
192 studies found for:    Open Studies | "Cardiomyopathies"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Cardiomyopathies"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Condition: Cardiomyopathy
Intervention: Drug: Ranolazine
2 Recruiting Intracoronary Transplantation of Bone Marrow Derived Mononuclear Cells in Pediatric Cardiomyopathy
Condition: Cardiomyopathy
Intervention: Biological: Mono Nuclear Cell (MNC) transplantation
3 Recruiting Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-Induced Cardiomyopathy
Condition: Cardiomyopathy
Intervention: Device: Three-lead CRT-D (Defibrillator)
4 Recruiting A Clinical Study of Immunoadsorption Therapy for Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention: Procedure: protein A immunoadsorption
5 Recruiting Cardiomyopathy Arrhythmia Risk Evaluation
Condition: Cardiomyopathy
Intervention:
6 Recruiting The Role of Emotional Stress in Patients With Stress-induced Cardiomyopathy
Condition: Takotsubo Cardiomyopathy
Intervention:
7 Not yet recruiting Evaluate the Efficacy of Disopyramide Therapy in Hypertrophic Obstructive Cardiomyopathy Patients
Condition: Cardiomyopathy
Intervention: Device: echocardiography
8 Not yet recruiting Bromocriptine in the Treatment of Peripartum Cardiomyopathy
Condition: Peripartum Cardiomyopathy
Interventions: Drug: Bromocriptine;   Other: Guideline-driven medical therapy (GDMT)
9 Recruiting Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Interventions: Device: protein A immunoadsorption;   Device: pseudo-immunoadsorption
10 Recruiting French Hypertrophic Cardiomyopathy Observatory
Condition: Hypertrophic Cardiomyopathy
Intervention:
11 Recruiting Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy
Condition: Cardiomyopathy
Intervention: Genetic: Identification of genetic polymorphisms
12 Recruiting Intravenous Administration of Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) in Patients With Recent Onset Anthracycline-Associated Cardiomyopathy
Condition: Cardiomyopathy
Interventions: Biological: Human Mesenchymal Stem Cells (hMSCs);   Other: Standard of Care
13 Not yet recruiting The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
Condition: Cardiomyopathy, Hypertrophic
Intervention:
14 Recruiting Brain fMRT In Takotsubo Cardiomyopathy
Condition: Takotsubo Cardiomyopathy
Intervention:
15 Recruiting Clinical and Genetic Examinations of Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy
Intervention:
16 Not yet recruiting Risk Stratification of Heart Failure in Cardiomyopathies.
Condition: Cardiomyopathy With Unknown Etiology
Interventions: Drug: etiologic treatment,anti-myocardial remodeling;   Drug: anti-myocardial remodeling;   Drug: anti-myocardial remodeling,anti-acute heart failure;   Drug: Etiological, anti-remodeling and symptom treatment
17 Recruiting Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy
Interventions: Procedure: Noncontrast echocardiography;   Procedure: Contrast Echocardiography;   Procedure: Cardiac magnetic resonance imaging
18 Recruiting Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy
Condition: Cardiomyopathy, Dilated
Intervention: Biological: Autologous stem cell therapy
19 Recruiting PHOspholamban RElated CArdiomyopathy STudy - Intervention
Condition: Phospholamban R14del Mutation-related Cardiomyopathy
Intervention: Drug: Eplerenone
20 Recruiting Mesenchymal Stem Cells for Idiopathic Dilated Cardiomyopathy
Condition: Primary Idiopathic Dilated Cardiomyopathy
Interventions: Other: bone marrow-derived MSCs injection;   Other: placebo intervention

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.